SEC Form 4 · accession 0001144204-15-018083

CORCEPT THERAPEUTICS INC · CORT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners

Longitude Venture Partners L.P.

Director · 10% Owner

Longitude Capital Associates, L.P.

10% Owner

Longitude Capital Partners, LLC

10% Owner

Bakker Juliet Tammenoms

10% Owner

Period of report

Mar 20, 2015

Accepted (ET)

Mar 24, 2015 · 4:06 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001088856

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Mar 20, 2015	X	634,516	$2.77	A	13,145,097	D
Common Stock^F1	Mar 20, 2015	S	300,447	$5.85	D	12,844,650	D
Common Stock^F1	Mar 20, 2015	X	486,443	$2.77	A	13,331,093	D
Common Stock^F1	Mar 20, 2015	S	230,333	$5.85	D	13,100,760	D
Common Stock^F4	Mar 20, 2015	X	9,750	$2.77	A	182,742	I	By LCA
Common Stock^F4	Mar 20, 2015	S	4,617	$5.85	D	178,125	I	By LCA
Common Stock^F1	Mar 24, 2015	X	1,130,709	$2.77	A	14,231,469	D
Common Stock^F1	Mar 24, 2015	S	554,348	$5.65	D	13,677,121	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Warrant (Right to Buy)^F1	$2.77	Mar 20, 2015	X	634,516	D	Mar 25, 2008	Mar 24, 2015	Common Stock	634,516	1,130,709	D
Warrant (Right to Buy)^F1	$2.77	Mar 20, 2015	X	486,443	D	Feb 6, 2009	Mar 24, 2015	Common Stock	486,443	0	D
Warrant (Right to Buy)^F4	$2.77	Mar 20, 2015	X	9,750	D	Feb 6, 2009	Mar 24, 2015	Common Stock	9,750	0	I
Warrant (Right to Buy)^F1	$2.77	Mar 24, 2015	X	1,130,709	D	Mar 25, 2008	Mar 24, 2015	Common Stock	1,130,709	0	D

Explanation of responses

F1Reflects transactions and holdings of shares of common stock of the Issuer held of record by Longitude Venture Partners, L.P. ("LVP"). This report is filed jointly by LVP, Longitude Capital Partners, LLC ("Longitude Capital") and Juliet Tammenoms Bakker with respect to the securities held and transactions effected by LVP. LVP may also be deemed a director by virtue of its right to nominate a representative to serve on the Issuer's Board of Directors. Patrick G. Enright currently serves as LVP's representative on the Issuer's Board of Directors and files separate reports under Section 16(a) of the Securities Exchange Act of 1934 to report transactions in securities of the Issuer. Each of Longitude Capital and Ms. Bakker disclaims beneficial ownership of these securities, except to the extent of their respective pecuniary interest therein.
F2On March 20, 2015, LVP exercised a warrant to purchase 634,516 shares of the Issuer's common stock for an exercise price of $2.77 per share. LVP paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 300,447 of such shares to pay the exercise price and issuing to LVP the remaining 334,069 shares. In connection with such exercise, the Issuer also paid to LVP $5.63 in cash in lieu of a fractional share.
F3On March 20, 2015, LVP exercised a warrant to purchase 486,443 shares of the Issuer's common stock for an exercise price of $2.77 per share. LVP paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 230,333 of such shares to pay the exercise price and issuing to LVP the remaining 256,110 shares. In connection with such exercise, the Issuer also paid to LVP $0.94 in cash in lieu of a fractional share.
F4Reflects transactions and holdings of shares of common stock of the Issuer held of record by Longitude Capital Associates, L.P. ("LCA"). This report is jointly filed by LCA, Longitude Capital and Ms. Bakker with respect to the securities held and transactions effected by LCA. Each of Longitude Capital and Ms. Bakker disclaims beneficial ownership of these securities, except to the extent of their respective pecuniary interest therein.
F5On March 20, 2015, LCA exercised a warrant to purchase 9,750 shares of the Issuer's common stock for an exercise price of $2.77 per share. LCA paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 4,617 of such shares to pay the exercise price and issuing to LCA the remaining 5,133 shares. In connection with such exercise, the Issuer also paid to LCA $1.95 in cash in lieu of a fractional share.
F6On March 24, 2015, LVP exercised a warrant to purchase 1,130,709 shares of the Issuer's common stock for an exercise price of $2.77 per share. LVP paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 554,348 of such shares to pay the exercise price and issuing to LVP the remaining 576,361 shares. In connection with such exercise, the Issuer also paid to LVP $2.27 in cash in lieu of a fractional share.